HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity

BACKGROUND: Current HIV-1 envelope glycoprotein (Env) vaccines are unable to induce cross-reactive neutralizing antibodies. However, such antibodies are elicited in 10-30% of HIV-1 infected individuals, but it is unknown why these antibodies are induced in some individuals and not in others. We hypo...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Kerkhof, Tom L G M, Feenstra, K Anton, Euler, Zelda, van Gils, Marit J, Rijsdijk, Linda W E, Boeser-Nunnink, Brigitte D, Heringa, Jaap, Schuitemaker, Hanneke, Sanders, Rogier W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849187/
https://www.ncbi.nlm.nih.gov/pubmed/24059682
http://dx.doi.org/10.1186/1742-4690-10-102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849187/
https://www.ncbi.nlm.nih.gov/pubmed/24059682
http://dx.doi.org/10.1186/1742-4690-10-102

Ejemplares similares